Ian Taylor - 01 Mar 2022 Form 4 Insider Report for ARVINAS, INC. (ARVN)

Role: Chief Scientific Officer
Signature: /s/ Matthew Batters as attorney-in-fact for Ian Taylor
Issuer symbol: ARVN
Transactions as of: 01 Mar 2022
Net transactions value: +$56,000
Form type: 4
Filing time: 03 Mar 2022, 20:00:27 UTC
Previous filing: 04 Mar 2022
Next filing: 01 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARVN	Common Stock	Options Exercise	$56,000	+3,500	+4.5%	$16.00	82,145	01 Mar 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ARVN	Stock Option (right to buy)	Options Exercise	$0	-596	-100%	$0.000000^*	0	01 Mar 2022	Common Stock	596	$16.00	Direct	F1
transaction	ARVN	Stock Option (right to buy)	Options Exercise	$0	-925	-6.3%	$0.000000	13,872	01 Mar 2022	Common Stock	925	$16.00	Direct	F2
transaction	ARVN	Stock Option (right to buy)	Options Exercise	$0	-1,979	-22%	$0.000000	6,964	01 Mar 2022	Common Stock	1,979	$16.00	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2019, with the remainder of the shares vesting in equal monthly installments following January 1, 2019 through January 1, 2022.
F2	This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of June 28, 2019, with the remainder of the shares vesting in equal monthly installments following June 28, 2019 through June 28, 2022.
F3	This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of March 31, 2019, with the remainder of the shares vesting in equal monthly installments following March 31, 2019 through March 31, 2022.